The Latest in Multiple Sclerosis

Clinical Neurology News

2017 update to McDonald criteria loosens MS diagnosis somewhat

January 9, 2018

Multiple Sclerosis

Clinical Neurology News

Two MS diagnostic criteria found to have similar accuracy

January 8, 2018

Multiple Sclerosis

Clinical Neurology News

Rituximab may outperform some other first-line multiple sclerosis treatments

January 8, 2018

Multiple Sclerosis

Clinical Neurology News

FDA cites manufacturer of autologous stem cells for regulatory, manufacturing missteps

January 5, 2018

Neurology Reviews

MRI Reveals Lymphatic Vessels in Dura

January 3, 2018

Neurology Reviews

Ibudilast May Slow Brain Atrophy in Progressive MS

January 2, 2018

Multiple Sclerosis

Clinical Neurology News

FDA: Gadolinium retention prompts new GBCA class warning, safety measures

December 21, 2017

Clinical Neurology News

FDA: Gadolinium retention prompts new GBCA class warning, safety measures

December 20, 2017

Neurology Reviews

Ozanimod Is Superior to Interferon in Relapsing-Remitting MS

December 11, 2017

Multiple Sclerosis

Neurology Reviews

2017 MS Highlights: The Year in Review

December 6, 2017

Multiple Sclerosis

Neurology Reviews

Revised McDonald Criteria Allow Substitution for Dissemination in Time

November 29, 2017

Multiple Sclerosis

Neurology Reviews

Durable Improvements in Clinical Outcomes With Alemtuzumab: Seven-Year Follow-Up

November 29, 2017

Multiple Sclerosis

Neurology Reviews

Fingolimod Reduces Annualized Relapse Rate in Pediatric MS

November 28, 2017

Multiple Sclerosis

Neurology Reviews

Oligoclonal Bands Could Be a Valuable Criterion for the Diagnosis of MS

November 28, 2017

Multiple Sclerosis

Neurology Reviews

Does Concussion Increase the Risk of MS?

November 28, 2017

Multiple Sclerosis